Upon encountering tumor-associated antigens presented by MHC class II molecules on professional APCs, CD4+ T cells differentiate into specialized subsets—including Th1, Th2, Th17, Tfh, and Tregs —each with distinct transcriptional profiles, cytokine outputs, and functional consequences for the TME (Fig. 2). This evidence concerns the gene CD4 and neoplasm.